Verition Fund Management
FOLD

Verition Fund Management’s Amicus Therapeutics FOLD Stock Holding History

Verition Fund Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.5M Buy
1,000,000
+350,438
+54% +$5.02M 0.09% 217
2025
Q4 		$9.25M Buy
649,562
+499,506
+333% +$4.91M 0.04% 508
2025
Q3 		$1.18M Sell
150,056
-1,364,995
-90% -$9.71M ﹤0.01% 2399
2025
Q2 		$8.68M Buy
1,515,051
+1,233,880
+439% +$7.96M 0.04% 611
2025
Q1 		$2.29M Buy
281,171
+153,414
+120% +$1.42M 0.01% 1475
2024
Q4 		$1.2M Buy
127,757
+105,333
+470% +$1.09M ﹤0.01% 1926
2024
Q3 		$239K Buy
22,424
+225
+1% +$2.45K ﹤0.01% 2774
2024
Q2 		$220K Buy
22,199
+3,432
+18% +$35.2K ﹤0.01% 2534
2024
Q1 		$221K Buy
+18,767
New +$240K ﹤0.01% 2450
2023
Q2 		– Sell
-26,859
Closed -$298K – 2312
2023
Q1 		$298K Buy
+26,859
New +$331K ﹤0.01% 1528
2020
Q1 		– Sell
-12,750
Closed -$124K – 770
2019
Q4 		$124K Sell
12,750
-64,494
-83% -$590K ﹤0.01% 1004
2019
Q3 		$619K Sell
77,244
-3,652
-5% -$39.6K 0.02% 557
2019
Q2 		$1.01M Buy
+80,896
New +$1.03M 0.03% 434
2015
Q2 		– Sell
-22,494
Closed -$245K – 652
2015
Q1 		$245K Buy
+22,494
New +$198K 0.03% 263

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Verition Fund Management's FOLD Position: Q1 2026 in Review

Verition Fund Management increased its Amicus Therapeutics (FOLD) stake by 54% in Q1 2026, buying an estimated $5.02M and bringing the position to 1,000,000 shares worth $14.5M. The position accounts for 0.09% of the portfolio, ranked #217.

Verition Fund Management first reported a position in FOLD in Q1 2015 and has held it in 14 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Verition Fund Management held 1,000,000 shares of Amicus Therapeutics worth $14.5M as of Q1 2026.
  • Verition Fund Management bought 350,438 Amicus Therapeutics shares in Q1 2026, an estimated $5.02M.
  • Amicus Therapeutics made up 0.09% of Verition Fund Management's portfolio in Q1 2026, its #217 holding.
  • Verition Fund Management first reported a position in Amicus Therapeutics in Q1 2015 and has held it in 14 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.